Table 3.
Crude HR (95% CI) | Adjusted HR (95% CI) | |
Male gender (reference) | 1 | 1 |
Female gender | 1.05 (0.95–1.16) | 1.15 (1.02–1.30) |
Caucasian (reference) | 1 | 1 |
Non-Caucasian | 1.02 (0.92–1.13) | 0.93 (0.82–1.05) |
Age > 40 years (vs. <= 40 years) | 1.12 (1.02–1.22) | 1.07 (0.97–1.18) |
CD4 count < 200 cells/μl (vs. ≥ 200 cell/μl) | 1.45 (1.32–1.59) | 1.38 (1.25–1.52) |
Viral load > 100,000 copies/ml (vs. ≤ 100,000 copies/ml) | 1.32 (1.21–1.45) | 1.14 (1.03–1.26) |
Heterosexual (reference) | 1 | 1 |
Homosexual | 1.01 (0.92–1.11) | 1.04 (0.93–1.17) |
Intravenous drug use | 0.85 (0.72–1.00) | 0.87 (0.73–1.04) |
Other/unknown | 1.05 (0.86–1.27) | 1.07 (0.88–1.31) |
Diagnosed before year 2000 (reference) | 1 | 1 |
Diagnosed after 1 January 2000 | 1.40 (1.28–1.53) | 1.40 (1.28–1.53) |
Centre | ||
Center 1 | 1 | 1 |
Center 2 | 1.03 (0.93–1.14) | 1.06 (0.95–1.17) |
Center 3 | 1.08 (0.91–1.27) | 1.12 (0.94–1.32) |
Center 4 | 0.87 (0.75–1.02) | 0.91 (0.78–1.07) |
Center 5–8* | 0.99 (0.86–1.15) | 0.98 (0.83–1.14) |
* The four smallest centers in the Danish HIV Cohort Study (DHCS)